| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |